Cerevel Therapeutics Announces Pricing of $254 Million Public Offering of Common Stock and Concurrent $300 Million Private Offering of Convertible Senior Notes
CAMBRIDGE, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) — Cerevel Therapeutics Holdings, Inc. (“Cerevel”, “we”, “us”…
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community
Columbus Therapist Yvonne Judge Seeks Participants for Doctoral Research on EMDR Therapy and Family Relationships
Saudi Arabia Hit 85% Digital: The Rails Under the Card Are Next
Creative Pass Studio Launches Unlimited Design Monthly Pass, Giving Agencies and Growing Businesses a Senior Creative Team Without Adding Headcount
Stardust Appoints Eamonn McHugh as CEO in Strategic Leadership Transition